2022 WAC-CREP conference

March 17-19, 2022
Yamoussoukro, Côte D’Ivoire

With a focus on emerging infectious diseases, the West Africa Consortium for Clinical Research (WAC-CREP) was borne out of a shared interest by Guinea, Liberia, Sierra Leone and Mali to advance regional preparedness for global health security by sharing regional research, best practices and evidence to inform infectious disease policy.

At the 5th annual WAC-CREP conference, being held in Yamoussoukro, Côte D’Ivoire, FHI Clinical employees are presenting findings from research being conducted within the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network.

Presentation Title
Presenter
The Importance of Research in Advocacy: Understanding the Evolution of Disease Support Networks During the Ebola Epidemic in Liberia
Patrick Seeco Faley
Assessing Strategy Management in the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL)
Jemee Tegli
Baseline Characteristics of Participants Enrolled in the PREVAIL COVID-19 Observational Study
Moses Badio
The Microbiology of Respiratory infections During the COVID-19 Pandemic in Liberia
Kumblytee Johnson
Benefits of Using a Biorepository to Support Clinical Research During COVID 19 Pandemic in Liberia
Julie Blie
The Impact of Women Engagement in Research: Lessons Learned From the PREVAIL InVITE Study
Barthalomew Wilson and Garmai Nyuangar
Diagnostic Performance of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR for Diagnosis of COVID-19 in Liberia
Moses Badio
Diagnosing COVID-19 in Primary Health Care Centers: A Key Response for the Continuum of Care During the Pandemic in Liberia
Christina Andrews
Establishing a Community Advisory Group to Enhance Community Participation in Clinical Research
Ophelia Talweh Bongolee
Description of Infection Rates Among Vaccinated and Unvaccinated Individuals in Liberia, Study of Vaccine Effectiveness in Resource-Limited Population
Tamba Fayiah
Operations and Logistics Associated in Testing and Enrolling Volunteers in the PREVAIL COVID-19 Observational Study
Princess Lobbo
Collaboration: A Key to Implementing the International Study on COVID-19 Vaccines to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE) in Liberia
Dehkontee L. Gayedyu-Dennis

Share this post

Share on linkedin
Share on twitter
Share on facebook